CACI International Secures Order to Support Defense Intelligence Agency National Center for Medical Intelligence

☀️Trending News

CACI ($NYSE:CACI) International Inc. is a leading provider of information solutions and services in support of national security missions and government transformation for intelligence, defense, and federal civilian customers. CACI has recently been awarded an order to provide support to the Defense Intelligence Agency National Center for Medical Intelligence (NCMI). The NCMI is a leader in providing world-class medical intelligence to the Department of Defense and other government agencies. Under this contract, CACI will provide expertise to NCMI to support the full spectrum of medical intelligence operations. They will also provide analysis, collection, operations support, and other technical services to ensure NCMI is able to provide solutions to complex challenges posed by adversaries in the medical domain.

CACI will also provide best practices for analyzing medical intelligence data, as well as ensuring that NCMI remains on the cutting edge of medical intelligence technologies. CACI is committed to helping NCMI achieve its mission of providing the most effective medical intelligence support in the world. This contract is a testament to their commitment to providing the highest quality services and solutions. CACI is confident that their experienced professionals and innovative solutions will allow NCMI to continue delivering the best medical intelligence possible.

Market Price

The order was secured through an existing contract with NCMI and will enhance its mission-critical operations in medical intelligence. In reaction to the news, CACI INTERNATIONAL stock opened at $321.0 and closed at $318.2, down by 0.5% from its previous closing price of $319.7. CACI’s success in securing this order indicates the company’s ability to provide sophisticated solutions for the defense and intelligence sectors of the government. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Caci International. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Caci International. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Caci International. More…

Key Ratios Snapshot

Some of the financial key ratios for Caci International are shown below. More…

Analysis

GoodWhale has conducted an analysis of CACI INTERNATIONAL‘s wellbeing and, based on the Star Chart, we have determined that the company is strong in growth, medium in profitability, and weak in asset and dividend. Looking at this information, we classified CACI INTERNATIONAL as a ‘rhino’, which we presume to be companies that have achieved moderate revenue or earnings growth. Considering this data, investors looking for consistent medium-term growth may be interested in CACI INTERNATIONAL. Additionally, with a high health score of 8/10, CACI INTERNATIONAL is capable of safely riding out any crisis without the risk of bankruptcy due to its healthy cashflows and debt. More…

Peers

The company has over 20,000 employees, and its annual revenue is over $4 billion. CACI provides services to both the public and private sector, and its clients include the US federal government, state and local governments, and commercial enterprises. The company has a strong focus on the defense and intelligence sector, and its main competitors are Atos SE, Jiayuan Science and Technology Co Ltd, and Almunda Professionals N.V.

– Atos SE ($OTCPK:AEXAY)

Atos SE is a French multinational corporation focused on digital transformation, artificial intelligence, cloud computing, and cybersecurity. The company is headquartered in Bezons, France, and serves clients in over 180 countries.

As of 2022, Atos SE has a market capitalization of 965.45 million euros and a return on equity of -44.22%. The company has been focused on digital transformation, artificial intelligence, cloud computing, and cybersecurity.

– Jiayuan Science and Technology Co Ltd ($SZSE:301117)

Jiayuan Science and Technology Co Ltd is a Chinese company that specializes in the development, manufacturing, and sale of LED products. The company has a market cap of 6.39 billion as of 2022 and a return on equity of 5.39%. Jiayuan Science and Technology Co Ltd was founded in 2001 and is headquartered in Shenzhen, China.

– Almunda Professionals N.V ($LTS:0QR5)

Almunda Professionals N.V is a market leader in providing professional services to the energy industry. The company has a strong focus on safety and quality, and is dedicated to providing its clients with the highest level of service possible. Almunda Professionals N.V has a market cap of 4.74M as of 2022, a Return on Equity of 18.9%. The company’s strong financial position and commitment to quality make it an attractive option for investors.

Summary

CACI International Inc. is a leading provider of information solutions and IT services to the U.S. government, primarily in the defense and intelligence markets. Recently, they secured an order to provide specialized IT solutions and support to the Defense Intelligence Agency National Center for Medical Intelligence. This order presents an interesting investment opportunity with CACI. The company has consistently reported positive revenue growth and increased its EPS for the past four years.

Their long-term debt-to-equity ratio is low, indicating that they have strong liquidity and financial position, and their dividend yield is above average. The new order may represent a big opportunity for CACI to expand its intelligence solutions offerings, and the company’s track record suggests that it is well-positioned to capitalize on it. With a good financial position, a solid history of growth, and a potentially lucrative order, CACI could be an attractive investment opportunity.